SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
嗯哼
Lv1
60 积分
2024-05-20 加入
最近求助
最近应助
互助留言
Specifically Targeting the Interface Between HER1-HER3 Heterodimer on Breast Cancer to Limit Off-Target Effects Using Chimeric Antigen Receptor Designs with Improved T-Cell Energy Balance
7天前
已完结
Specifically Targeting the Interface Between HER1-HER3 Heterodimer on Breast Cancer to Limit Off-Target Effects Using Chimeric Antigen Receptor Designs with Improved T-Cell Energy Balance
7天前
已关闭
Specifically Targeting the Interface Between HER1-HER3 Heterodimer on Breast Cancer to Limit Off-Target Effects Using Chimeric Antigen Receptor Designs with Improved T-Cell Energy Balance
7天前
已关闭
Specifically Targeting the Interface Between HER1-HER3 Heterodimer on Breast Cancer to Limit Off-Target Effects Using Chimeric Antigen Receptor Designs with Improved T-Cell Energy Balance
7天前
已关闭
Programming CAR-T cells to kill cancer
12天前
已完结
HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non-Small Cell Lung Cancer
12天前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
16天前
已完结
Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study
1个月前
已完结
Non-small-cell lung cancer
1个月前
已完结
Molecular dynamics at immune synapse lipid rafts influence the cytolytic behavior of CAR T cells
2个月前
已完结
没有进行任何应助
感谢
12天前
感谢
16天前
感谢
2个月前
非常感谢
3个月前
重新求助【积分已退回】
3个月前
已有文章【积分已退回】
3个月前
非常感谢!
6个月前
非常感谢!
6个月前
谢谢~
6个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论